** Brokerage UBS downgrades life and health reinsurer Reinsurance Group of America RGA.N to "neutral" from "buy"; cuts PT to $216 from $250
** Cites execution risk on annual capital deployment target as well as on the Equitable Holdings EQH.N deal
** Says the recent overhang on shares to persist over the near term as management executes its newer, more aggressive growth strategy
** "Reliance on 3rd party capital to meet EPS growth can be seen as "stretching" for a global reinsurance franchise historically known for its conservativism," says brokerage
** Nine of 12 brokerages rate stock "buy" or higher, and 3 "hold"; median PT is $250 — LSEG data
** Including session moves, RGA stock down ~6.7% YTD, compared to a 4.2% decline in the S&P 500 .SPX
(Reporting by Ateev Bhandari in Bengaluru)
((Ateev.Bhandari@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。